Short Talk: The Hepatic Crown-like Structure in NASH: A Nexus between Monocyte-Derived Macrophages, Hepatic Stellate Cells, and Tissue Fibrosis iconShort Talk: The Hepatic Crown-like Structure in NASH: A Nexus between Monocyte-Derived Macrophages, Hepatic Stellate Cells, and Tissue Fibrosis

Short Talk: The Hepatic Crown-like Structure in NASH: A Nexus between Monocyte-Derived Macrophages, Hepatic Stellate Cells, and Tissue Fibrosis

Mar 23, 2021 6:00pm ‐ Mar 23, 2021 6:15pm
Short Talk: Lipid-Induced Endothelial Vascular Cell Adhesion Molecule 1 Promotes Nonalcoholic Steatohepatitis Pathogenesis iconShort Talk: Lipid-Induced Endothelial Vascular Cell Adhesion Molecule 1 Promotes Nonalcoholic Steatohepatitis Pathogenesis

Short Talk: Lipid-Induced Endothelial Vascular Cell Adhesion Molecule 1 Promotes Nonalcoholic Steatohepatitis Pathogenesis

Mar 23, 2021 6:15pm ‐ Mar 23, 2021 6:30pm
Short Talk: Immunity-Related GTPase IFGGA2 Induces Degradation of Hepatic Lipids by Lipophagy iconShort Talk: Immunity-Related GTPase IFGGA2 Induces Degradation of Hepatic Lipids by Lipophagy

Short Talk: Immunity-Related GTPase IFGGA2 Induces Degradation of Hepatic Lipids by Lipophagy

Mar 23, 2021 6:30pm ‐ Mar 23, 2021 6:45pm
DGAT2 Inhibition for NASH iconDGAT2 Inhibition for NASH

DGAT2 Inhibition for NASH

Mar 24, 2021 9:00am ‐ Mar 24, 2021 9:25am
Emerging Therapies for NASH iconEmerging Therapies for NASH

Emerging Therapies for NASH

Mar 24, 2021 9:00am ‐ Mar 24, 2021 12:25pm
Combination Therapies for NASH Cirrhosis iconCombination Therapies for NASH Cirrhosis

Combination Therapies for NASH Cirrhosis

Mar 24, 2021 9:25am ‐ Mar 24, 2021 9:50am
Inhibition of Fructose Metabolism for the Treatment of NAFLD iconInhibition of Fructose Metabolism for the Treatment of NAFLD

Inhibition of Fructose Metabolism for the Treatment of NAFLD

Mar 24, 2021 10:15am ‐ Mar 24, 2021 10:40am
Coffee Break iconCoffee Break

Coffee Break

Mar 24, 2021 10:40am ‐ Mar 24, 2021 10:50am
Therapeutic FGF19 in Non-Alcoholic Steatohepatitis iconTherapeutic FGF19 in Non-Alcoholic Steatohepatitis

Therapeutic FGF19 in Non-Alcoholic Steatohepatitis

Mar 24, 2021 10:50am ‐ Mar 24, 2021 11:15am
Short Talk: A Drug-Like Sphingolipid Opposes Mitochondrial Fragmentation and Corrects the Metabolic Sequelae of Obesity iconShort Talk: A Drug-Like Sphingolipid Opposes Mitochondrial Fragmentation and Corrects the Metabolic Sequelae of Obesity

Short Talk: A Drug-Like Sphingolipid Opposes Mitochondrial Fragmentation and Corrects the Metabolic Sequelae of Obesity

Mar 24, 2021 11:15am ‐ Mar 24, 2021 11:30am